Cargando…

The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects

BACKGROUND: Subjects are considered infected with Trypanosoma cruzi when tested positive by at least two out of three serological tests, whereas a positive result in only one of up to three tests is termed “serodiscordant” (SD). Assessment of parasite-specific T-cell responses may help discriminate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro Eiro, Melisa D., Alvarez, María G., Cooley, Gretchen, Viotti, Rodolfo J., Bertocchi, Graciela L., Lococo, Bruno, Albareda, María C., De Rissio, Ana M., Natale, María A., Parodi, Cecilia, Tarleton, Rick L., Laucella, Susana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605634/ https://www.ncbi.nlm.nih.gov/pubmed/28966620 http://dx.doi.org/10.3389/fimmu.2017.01141

Ejemplares similares

Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses
por: Alvarez, María G., et al.
Publicado: (2016)

Correction: Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
por: Natale, María A., et al.
Publicado: (2019)

Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
por: Natale, María A., et al.
Publicado: (2018)

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease
por: Viotti, Rodolfo, et al.
Publicado: (2011)

Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes
por: Albareda, María C., et al.
Publicado: (2018)

Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease
por: Argüello, Rafael J., et al.
Publicado: (2012)

Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy
por: Pérez-Mazliah, Damián E., et al.
Publicado: (2018)

Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease
por: Pengue, Claudia, et al.
Publicado: (2019)

Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro
por: Natale, María Ailén, et al.
Publicado: (2021)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
por: Albareda, María Cecilia, et al.
Publicado: (2015)

Polyfunctional T Cell Responses in Children in Early Stages of Chronic Trypanosoma cruzi Infection Contrast with Monofunctional Responses of Long-term Infected Adults
por: Albareda, María C., et al.
Publicado: (2013)

Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole
por: Castro Eiro, Melisa D., et al.
Publicado: (2022)

High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection
por: Cooley, Gretchen, et al.
Publicado: (2008)

Allopurinol reduces antigen-specific and polyclonal activation of human T cells
por: Pérez-Mazliah, Damián, et al.
Publicado: (2012)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection
por: Hartley, Ashley N, et al.
Publicado: (2014)

Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta
por: Dolcini, Guillermina Laura, et al.
Publicado: (2008)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency
por: Perrone, Alina E., et al.
Publicado: (2023)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

HLA Class I-T Cell Epitopes from trans-Sialidase Proteins Reveal Functionally Distinct Subsets of CD8(+) T Cells in Chronic Chagas Disease
por: Alvarez, María G., et al.
Publicado: (2008)

Chromosome level assembly of the hybrid Trypanosoma cruzi genome
por: Weatherly, D Brent, et al.
Publicado: (2009)

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
por: Teixeira, Antonio R. L., et al.
Publicado: (2011)

Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas
por: Fabbro, Diana L., et al.
Publicado: (2014)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2020)

A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease
por: Nagarkatti, Rana, et al.
Publicado: (2020)

Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon
por: Santana, Rosa Amélia Gonçalves, et al.
Publicado: (2014)

Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi
por: Xu, Dan, et al.
Publicado: (2009)

Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022)

Structure, Properties, and Function of Glycosomes in Trypanosoma cruzi
por: Quiñones, Wilfredo, et al.
Publicado: (2020)

CD8(+) T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes
por: Martin, Diana L, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_k3l0q23o5mqnbfm4hs2lhd0j0g